HG-1130

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1130

Drug Alias NameADAM-27 modulator (Human Genome Sciences)TACE modulator (Human Genome Sciences)TACE-like protein modulator (Human Genome Sciences)metalloproteinase modulator (Human Genome Sciences)tMDCIII modulator (Human Genome Sciences) +[9]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 modulators

TargetsDisintegrin and metalloproteinase domain-containing protein 17

Therapy Area/Indications +[1] N/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive Indications +[1] N/A

Other Information

ATC CodeN/A